Trademark: 97763089
Word
NANOTEIN TECHNOLOGIES
Status Date
Tuesday, February 27, 2024
Registration Number
7314330
Registration Date
Tuesday, February 27, 2024
Filing Date
Friday, January 20, 2023
Published for Opposition
Tuesday, December 12, 2023
5 Cell therapy reagents for use in vitro for medical use; biopharmaceuticals, namely, engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in vitro for medical use, namely, the treatment of cancer; biopharmaceuticals, namely, self-assembling protein-based nanoparticles for use in vitro for medical use, namely, the treatment of cancer; T-cell activator being reagents for use in vitro for medical use
1 Cell therapy reagents for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in medical and scientific research in vitro and for use in the manufacture of cell therapy biopharmaceuticals in vitro; self-assembling protein-based nanoparticles for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; T-cell activator in the nature of cell culture media for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro
Feb 27, 2024
Notice Of Registration Confirmation Emailed
Feb 27, 2024
Registered-Principal Register
Dec 12, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2023
Published For Opposition
Nov 22, 2023
Notification Of Notice Of Publication E-Mailed
Nov 7, 2023
Approved For Pub - Principal Register
Nov 7, 2023
Examiner's Amendment Entered
Nov 7, 2023
Notification Of Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment -Written
Nov 7, 2023
Previous Allowance Count Withdrawn
Nov 7, 2023
Approved For Pub - Principal Register
Nov 7, 2023
Examiner's Amendment Entered
Nov 7, 2023
Notification Of Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment -Written
Nov 3, 2023
Teas/Email Correspondence Entered
Nov 2, 2023
Correspondence Received In Law Office
Nov 2, 2023
Teas Response To Office Action Received
Oct 18, 2023
Notification Of Non-Final Action E-Mailed
Oct 18, 2023
Non-Final Action E-Mailed
Oct 18, 2023
Non-Final Action Written
Oct 18, 2023
Assigned To Examiner
Feb 10, 2023
New Application Office Supplied Data Entered
Jan 24, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
